SOURCE Charming Shoppes, Inc.
The drug is responsible for more than 60% of AbbVie's top line.
Private equity firms' publicly traded equity holdings are a valuable source of ideas for growth and value investors, alike.
The Patent Trial and Appeal Board has denied Coherus's petition to make a copy of AbbVie's Humira drug.
©1996-2017 TheStreet, Inc. All rights reserved.
Action Alerts PLUS is a registered trademark of TheStreet, Inc.